Abstract
The aim was to study levels of VEGFA, VEGFC, sVEGFR1, sVEGFR3 and TGFβ1 in malignant gastric, peritoneal and omental tissues. Materials and methods. 62 patients were enrolled in the study: 21 (10, 11) -stomach cancer T 3-4а N 0-3 M 1 and metastases to the peritoneum; 24 (15, 9) - stomach cancer T 3-4а N 0-3 M 0 without metastasis; 17 (6, 11) - non-cancer patients (controls). Levels of growth factors and their receptors were measured by ELISA in tissues of the peritoneum, greater omentum, gastric tumors (GT) and their perifocal tissues (PT). Results. All patients had elevated GT and PT levels of VEGFА and VEGFR1, but not VEGFСand VEGFR3; GT tissues contained more VEGFR1, and PT - more VEGFА. Only metastatic peritoneum and omentum showed increased levels of VEGFs: in the omentum -VEGFА (by 2.8 times), VEGFС (by 2.7 times), VEGFR1 (by 2.3 times), VEGFR3 (by 1.6 times (p<0.05)); in the peritoneum - VEGFА (by 4.2 times0, VEGFС (by 3.5 times), VEGFR1 (by 2.5 times), VEGFR3 (by 2.3 times). The TGF-β1 level increased in GT, PT and omentum tissues in all patients despite metastases, while peritoneal TGF-β1 levels sharply increased - by 3.1 times with metastases and decreased - by 1.8 times (p<0.05) without ones. Conclusion. The role of VEGFА and TGFβ1 in omental and peritoneal metastasis from gastric cancer was confirmed.
Highlights
The role of VEGFА and TGFβ1 in omental and peritoneal metastasis from gastric cancer was confirmed
62 patients were enrolled in the study
their receptors were measured by ELISA in tissues
Summary
62 patients were enrolled in the study: 21 (10 , 11 ) –stomach cancer T3–4аN0–3M1 and metastases to the peritoneum; 24 (15 , 9 ) — stomach cancer T3–4аN0–3M0without metastasis; 17 (6 , 11 ) — non-cancer patients (controls). Levels of growth factors and their receptors were measured by ELISA in tissues of the peritoneum, greater omentum, gastric tumors (GT) and their perifocal tissues (PT)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have